Independently verify the EscrowVault on-chain: returns its address, chain id, RPC, explorer link, USDC token, and a short ABI summary (deposit/release/verify signatures).
| Name | Required | Description | Default |
|---|---|---|---|
No arguments | |||
| Name | Required | Description | Default |
|---|---|---|---|
| chain | No | ||
| message | No | ||
| rpc_url | No | ||
| chain_id | No | ||
| configured | Yes | ||
| usdc_token | No | ||
| abi_summary | No | ||
| explorer_url | No | ||
| verify_recipe | No | ||
| contract_address | No |
Changes observed during successful MCP inspections. Dates show when Glama detected each change.
Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?
Annotations already declare readOnlyHint=true, idempotentHint=true, and destructiveHint=false. The description adds what the agent can expect: the returned fields and the fact the ABI summary covers deposit/release/verify signatures. 'Independently' also hints at a direct on-chain call rather than a cached value.
Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.
Is the description appropriately sized, front-loaded, and free of redundancy?
A single dense sentence front-loads the action ('Independently verify'), then lists the concrete return details in a compact, readable form. There is no filler or repetition of schema/annotation information.
Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.
Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?
With zero parameters, no input guidance is needed. The description states exactly what is returned, the output schema covers structured details, and annotations handle the safety profile. The tool definition is fully adequate for correct invocation.
Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.
Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?
The tool has zero parameters and schema description coverage is 100%, so the baseline 4 applies. No parameter explanation is needed; the description's focus on return values is appropriate.
Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.
Does the description clearly state what the tool does and how it differs from similar tools?
The description uses a specific verb ('verify') and resource ('EscrowVault on-chain'), then enumerates the exact return items: address, chain id, RPC, explorer link, USDC token, and ABI summary. This clearly sets it apart from sibling tools like data_session_attach_escrow or get_agent_contract.
Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.
Does the description explain when to use this tool, when not to, or what alternatives exist?
The phrase 'Independently verify the EscrowVault on-chain' establishes a clear context: use this tool when you need to confirm contract details directly from the chain. It does not explicitly name alternatives or exclusions, so it stops short of a 5.
Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.
Add one secure layer between your agents and this server.
The tool set blends FDA recall query tools with generic A2AWire marketplace tools, making purpose boundaries unclear. Multiple tools overlap: data_session_fund, data_session_funding_package, and data_session_open all describe payment/session setup, while a2awire_guide and get_recommended_action both serve as navigational helpers.
Some tools follow a verb_noun pattern (data_session_open, data_session_query, discover_agents), but others are inconsistent or vague (a2awire_guide, check_earnings, register, verify_contract). The mix of domain-specific and platform tool naming with no coherent convention makes the surface feel disjointed.
16 tools is not inherently excessive, but most are unrelated to FDA recall alerts; they cover agent registration, onboarding, escrow, hiring, and earnings. Only a handful actually concern the stated FDA recall data domain, so the count is poorly scoped for the server's apparent purpose.
For an FDA recall alert server, the surface is severely incomplete: there is no direct recall listing, search, filtering, or detail tool, only a generic data_session_query with preview. The remaining tools are platform infrastructure, leaving the actual recall domain shallow and dependent on an opaque paid query flow.